Literature DB >> 25017538

Predisposition to infection and SIRS in mitochondrial disorders: 8 years' experience in an academic center.

Melissa A Walker1, Nancy Slate2, Alexandra Alejos3, Stefano Volpi4, Rajashri S Iyengar3, David Sweetser5, Katherine B Sims1, Jolan E Walter6.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25017538     DOI： 10.1016/j.jaip.2014.02.009

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  17 in total

1.  Mitochondrial Dysfunction, Depleted Purinergic Signaling, and Defective T Cell Vigilance and Immune Defense.

Authors:  Carola Ledderose; Yi Bao; Stephan Ledderose; Tobias Woehrle; Maria Heinisch; Linda Yip; Jingping Zhang; Simon C Robson; Nathan I Shapiro; Wolfgang G Junger
Journal:  J Infect Dis       Date:  2015-07-06       Impact factor: 5.226

2.  C2orf69 mutations disrupt mitochondrial function and cause a multisystem human disorder with recurring autoinflammation.

Authors:  Eva Lausberg; Sebastian Gießelmann; Joseph P Dewulf; Elsa Wiame; Anja Holz; Ramona Salvarinova; Clara D van Karnebeek; Patricia Klemm; Kim Ohl; Michael Mull; Till Braunschweig; Joachim Weis; Clemens J Sommer; Stephanie Demuth; Claudia Haase; Claudia Stollbrink-Peschgens; François-Guillaume Debray; Cecile Libioulle; Daniela Choukair; Prasad T Oommen; Arndt Borkhardt; Harald Surowy; Dagmar Wieczorek; Norbert Wagner; Robert Meyer; Thomas Eggermann; Matthias Begemann; Emile Van Schaftingen; Martin Häusler; Klaus Tenbrock; Lambert van den Heuvel; Miriam Elbracht; Ingo Kurth; Florian Kraft
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

Review 3.  The emerging role of immune dysfunction in mitochondrial diseases as a paradigm for understanding immunometabolism.

Authors:  Senta M Kapnick; Susan E Pacheco; Peter J McGuire
Journal:  Metabolism       Date:  2017-11-21       Impact factor: 8.694

4.  Cytochrome c Oxidase Activity Is a Metabolic Checkpoint that Regulates Cell Fate Decisions During T Cell Activation and Differentiation.

Authors:  Tatyana N Tarasenko; Susan E Pacheco; Mary Kay Koenig; Julio Gomez-Rodriguez; Senta M Kapnick; Francisca Diaz; Patricia M Zerfas; Emanuele Barca; Jessica Sudderth; Ralph J DeBerardinis; Raul Covian; Robert S Balaban; Salvatore DiMauro; Peter J McGuire
Journal:  Cell Metab       Date:  2017-06-06       Impact factor: 27.287

5.  Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.

Authors:  Rohit Sharma; Bryn Reinstadler; Kristin Engelstad; Owen S Skinner; Erin Stackowitz; Ronald G Haller; Clary B Clish; Kerry Pierce; Melissa A Walker; Robert Fryer; Devin Oglesbee; Xiangling Mao; Dikoma C Shungu; Ashok Khatri; Michio Hirano; Darryl C De Vivo; Vamsi K Mootha
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 6.  The rise of mitochondria in medicine.

Authors:  Martin Picard; Douglas C Wallace; Yan Burelle
Journal:  Mitochondrion       Date:  2016-07-14       Impact factor: 4.160

Review 7.  Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Amel Karaa; Mary Kay Koenig; Irina Anselm; Catherine Brunel-Guitton; John Christodoulou; Bruce H Cohen; David Dimmock; Gregory M Enns; Marni J Falk; Annette Feigenbaum; Richard E Frye; Jaya Ganesh; David Griesemer; Richard Haas; Rita Horvath; Mark Korson; Michael C Kruer; Michelangelo Mancuso; Shana McCormack; Marie Josee Raboisson; Tyler Reimschisel; Ramona Salvarinova; Russell P Saneto; Fernando Scaglia; John Shoffner; Peter W Stacpoole; Carolyn M Sue; Mark Tarnopolsky; Clara Van Karnebeek; Lynne A Wolfe; Zarazuela Zolkipli Cunningham; Shamima Rahman; Patrick F Chinnery
Journal:  Genet Med       Date:  2017-07-27       Impact factor: 8.822

8.  Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations.

Authors:  Carolyn M Sue; Shanti Balasubramaniam; Drago Bratkovic; Catherine Bonifant; John Christodoulou; David Coman; Karen Crawley; Fabienne Edema-Hildebrand; Carolyn Ellaway; Roula Ghaoui; Maina Kava; Lisa S Kearns; Joy Lee; Christina Liang; David A Mackey; Sean Murray; Merrilee Needham; Rocio Rius; Jacqui Russell; Nicholas J C Smith; Dominic Thyagarajan; Christine Wools
Journal:  Intern Med J       Date:  2021-11-19       Impact factor: 2.611

9.  Elevated type I interferon responses potentiate metabolic dysfunction, inflammation, and accelerated aging in mtDNA mutator mice.

Authors:  Yuanjiu Lei; Camila Guerra Martinez; Sylvia Torres-Odio; Samantha L Bell; Christine E Birdwell; Joshua D Bryant; Carl W Tong; Robert O Watson; Laura Ciaccia West; A Phillip West
Journal:  Sci Adv       Date:  2021-05-26       Impact factor: 14.136

Review 10.  Powering the immune system: mitochondria in immune function and deficiency.

Authors:  Melissa A Walker; Stefano Volpi; Katherine B Sims; Jolan E Walter; Elisabetta Traggiai
Journal:  J Immunol Res       Date:  2014-09-21       Impact factor: 4.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.